Titan Medical has signed a non-binding letter of intent (LOI) with London Health Sciences Centre (LHSC) for testing and evaluation of the company's Amadeus Robotic Surgical Platform.
Under the terms of the LOI, LHSC will test and evaluate Titan’s surgeon console and its component sub-systems (including vision system, telecommunication system, hand controllers, simulated instrumentation, ergonomic interface) and will provide the company with detailed reports.
The testing and evaluation will take place in conjunction with CSTAR (Canadian Surgical Technologies & Advanced Robotics), LHSC’s program for the research, validation and training for emerging medical device technologies.
Titan Medical president Reiza Rayman said they are excited to have established their first Canadian-based relationship with LHSC as they are nearing the completion of their clinical-grade next generation robotic surgical system.
"LHSC has pioneering history and leadership in robotic surgery, and we look forward to capitalizing on their expertise in minimally invasive surgery technologies," Rayman said.